|
Radiation Therapy Oncology Group
|
3U10CA021661-34S2
|
$1,198,505
|
$11,985
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Tissue Bank
|
3U24CA114734-05S1
|
$1,040,063
|
$104,006
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-34
|
$12,451,705
|
$124,517
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Targeted tumoricidal bacteria
|
2R44CA126023-02
|
$374,950
|
$93,738
|
ZHAO, MING
|
ANTICANCER, INC.
|
|
Molecular Target Focused Discovery of Anticancer Drugs
|
5R01CA090441-08
|
$381,250
|
$53,375
|
PETTIT, GEORGE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
PDX-1 is a Therapeutic Target for Pancreatic Cancer
|
5R01CA095731-08
|
$274,814
|
$274,814
|
BRUNICARDI, FRANCIS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Dietary Zinc Transporter ZIP4 in Pancreatic Cancer
|
1R01CA138701-01A1
|
$318,513
|
$318,513
|
LI, MIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Roles of Zinc Transporter ZIP4 (SLC39A4) in Pancreatic Cancer Pathogenesis
|
5R21CA133604-02
|
$202,620
|
$202,620
|
LI, MIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-04
|
$3,089,219
|
$123,569
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S6
|
$100,000
|
$4,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-04S1
|
$250,400
|
$10,016
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Spatial and Temporal Regulation of Angiogenesis
|
5P01CA092644-07
|
$1,307,514
|
$65,376
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC
|
1U01CA151925-01
|
$705,824
|
$705,824
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
|
5K08CA129204-03
|
$135,270
|
$67,635
|
ZEISBERG, ELISABETH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
EndoPulse System for Endoscopic Ultrasound-Guided Therapy of Pancreatic Carcinoma
|
1R43CA150484-01A1
|
$472,957
|
$472,957
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
SBIR Topic 255: Evaluate Therapeutic Potential of Novel Immunomodulator, Imprime
|
N43CO100118-000
|
$159,140
|
$159,140
|
Antonysamy, Mary
|
BIOPOLYMER ENGINEERING, INC.:1183599
|
|
Inducing Chromosomal Damage Responses in Pancreatic Cancer
|
5R21CA133654-02
|
$214,500
|
$214,500
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
SEROLOGICAL MARKERS OF PERIODONTAL DISEASE AND PANCREATIC CANCER RISK
|
1R21CA139193-01A1
|
$247,225
|
$247,225
|
MICHAUD, DOMINIQUE
|
BROWN UNIVERSITY
|
|
Mitochondrial DNA Mutations in Pancreatic Cancer
|
5R21CA133080-02
|
$93,181
|
$93,181
|
Tranah, Gregory
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Fresno State-SBCC Partnership: Cancer Research & Training for Central PA (1 of 2)
|
1P20CA138025-01A1
|
$261,432
|
$130,716
|
JUNN, ELLEN
|
CALIFORNIA STATE UNIVERSITY FRESNO
|
|
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
|
5U01CA062502-17
|
$719,853
|
$7,199
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S1
|
$100,000
|
$1,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S2
|
$72,416
|
$724
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S3
|
$100,000
|
$1,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S4
|
$50,000
|
$500
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-21
|
$5,104,400
|
$51,044
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Regulation of microRNA-16 by benzyl isothiocyanate in pancreatic cancer
|
1R21CA149785-01A1
|
$204,885
|
$204,885
|
HALDAR, SUBRATA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Preclinical Studies on Polyunsaturated Fatty Acid-Taxoid Conjugate for IND Filing
|
2R44CA132396-02A1
|
$656,011
|
$164,003
|
GUPTA, RAMESH
|
CHEM-MASTER INTERNATIONAL, INC
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
5K05CA136967-02
|
$135,505
|
$6,775
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CXCL12/CXCR4 Signaling - A Novel Target for Pancreatic Intraepithelial Neoplasia
|
5K22CA134637-02
|
$191,700
|
$191,700
|
KIM, JOSEPH
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
5R01CA124648-04
|
$435,804
|
$43,580
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
CSHL CANCER CENTER SUPPORT GRANT
|
3P30CA045508-23S2
|
$4,236,444
|
$42,364
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Cancer Center Support Grant
|
3P30CA013696-37S1
|
$100,000
|
$1,000
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-37
|
$4,017,288
|
$40,173
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Dietary Factors and Risk of Pancreatic Cancer in a Pooled Analysis
|
5U01CA139578-03
|
$77,299
|
$77,299
|
GENKINGER, JEANINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
PTEN Tumor Suppressor and Signal Transduction
|
5R01CA082783-10
|
$241,297
|
$120,649
|
Parsons, Ramon
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of Inflammation and Stroma in Digestive Cancer
|
3U54CA126513-05S1
|
$59,906
|
$3,594
|
Wang, Timothy
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of Inflammation and Stroma in Digestive Cancer
|
5U54CA126513-05
|
$848,610
|
$50,917
|
Wang, Timothy
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Detection and Diagnosis of Pancreatic Carcinoma
|
2R01CA096924-05A1
|
$272,245
|
$272,245
|
GOLD, DAVID
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S1
|
$124,531
|
$2,491
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S2
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S3
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S4
|
$46,458
|
$929
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-46
|
$11,641,774
|
$232,835
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Genetics and Biology of Pancreatic Duct Adenocarcinoma
|
5P01CA117969-05
|
$1,899,242
|
$1,899,242
|
DePinho, Ronald
|
DANA-FARBER CANCER INSTITUTE
|
|
DF/HCC SPORE in Gastrointestinal Cancer
|
5P50CA127003-04
|
$2,300,001
|
$598,000
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
|
Prospective Cohort Collaborative in Pancreatic Cancer Epidemiology & Pathogenesis
|
5R01CA124908-05
|
$949,009
|
$949,009
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
|
Technology for sensitive and reliable mutational profiling in pancreatic cancer
|
5R21CA138280-02
|
$267,960
|
$267,960
|
Makrigiorgos, G.
|
DANA-FARBER CANCER INSTITUTE
|
|
The Genetics and Prevention of Gastrointestinal Cancers
|
2K24CA113433-06
|
$197,209
|
$65,079
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
|
Cohort Study of Biochemical and Genetic Risk Factors for Pancreatic Cancer
|
5K07CA140790-02
|
$177,867
|
$177,867
|
Wolpin, Brian
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Pancreas for this search: $97,136,974
|